Showing results (311-320 of 356) with videos related to
Sort By:
Pageof 36
Experimental Hematology|June 1, 1996
Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteersR D Huhn, E J Yurkow, R Tushinski, et al.Trials|April 4, 2025
Pragmatic clustered randomised control trial to evaluate a self-regulated learning intervention to be implemented in South Australian primary schools-study protocolS A Brinkman, B Lam, S Dawson, et al.The Journal of Infectious Diseases|January 6, 2018
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C VirusMichael Reid, Yifei Ma, Rebecca Scherzer, et al.BMC Infectious Diseases|April 18, 2015
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infectionAimee C Hodowanec, Rebecca D Lee, Kirsten E Brady, et al.Environmental Health Perspectives|May 4, 2005
Two outbreaks of occupationally acquired histoplasmosis: more than workers at riskGregory D Huhn, Connie Austin, Mark Carr, et al.Nuklearmedizin. Nuclear Medicine|June 1, 1988
[Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses]E Moser, C R Pickardt, K Mann, et al.Blood|April 1, 1997
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factorM Engelhard, G Brittinger, D Huhn, et al.Journal for Immunotherapy of Cancer|March 1, 2018
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancerWalburga Engel-Riedel, Jamie Lowe, Paulette Mattson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancerH Oettle, M Arning, U Pelzer, et al.Antiviral Therapy|November 2, 2018
Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C)Fred Poordad, Mitchell L Shiffman, Wayne Ghesquiere, et al.Pageof 36